Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Colorectal Cancer Control Program (CRCCP) Monitoring Activities. CDC is requesting approval to continue information collection via an annual survey, a clinic-level data collection instrument, and a quarterly recipient-level program update survey.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 186 (Monday, September 28, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 186 (Monday, September 28, 2026)]
[Notices]
[Pages 61229-61231]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-19766]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-26-1074; Docket No. CDC-2026-1552]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Colorectal Cancer Control Program (CRCCP) Monitoring Activities.
CDC is requesting approval to continue information collection via an
annual survey, a clinic-level data collection instrument, and a
quarterly recipient-level program update survey.
[[Page 61230]]
DATES: CDC must receive written comments on or before November 27,
2026.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2026-
1552 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: <a href="/cdn-cgi/l/email-protection#84ebe9e6c4e7e0e7aae3ebf2"><span class="__cf_email__" data-cfemail="b9d6d4dbf9daddda97ded6cf">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Colorectal Cancer Control Program (CRCCP) Monitoring Activities
(OMB Control No. 0920-1074, Exp. 6/30/2027)--Extension--National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is requesting
an Extension to Colorectal Cancer Control Program (CRCCP) Monitoring
Activities (OMB Control No. 0920-1074). CDC proposes information
collection using the Annual Awardee Survey, Clinic-Level Data
Collection Instrument, and Quarterly Program Update. Colorectal cancer
(CRC) is the fourth leading cause of death from cancer in the United
States among cancers that affect both men and women. There is
substantial evidence that CRC screening reduces the incidence of and
death from the disease. Screening for CRC can detect disease early when
treatment is more effective and prevent cancer by finding and removing
precancerous polyps. Of individuals diagnosed with early-stage CRC,
more than 90% live five or more years. Despite strong evidence
supporting screening, Behavioral Risk Factor Surveillance System
(BRFSS) data from 2022 showed that 62.1% of eligible Americans 45 to 75
years old are up to date with colorectal cancer screening and 32.3%
have never been screened. To reduce CRC morbidity, mortality, and
associated costs, use of CRC screening tests must be increased among
age-eligible adults with the lowest CRC screening rates.
The purpose of the Colorectal Cancer Control Program (CRCCP) is to
partner with health systems and their individual primary care clinics
to implement Evidence-based Interventions (EBIs) to increase CRC
screening among defined populations of adults ages 45-75 that have CRC
screening rates lower than the national, regional, or local rate. In
2025, CDC issued the funding opportunity, Changing Health Systems Using
Evidence-based Interventions to Increase Colorectal Cancer Screening
(DP25-0012), a 5-year cooperative agreement to increase CRC screening
among defined populations of adults. DP25-0012 funds recipients to
partner with health systems and their primary care clinics to implement
multiple EBIs, partner with organizations to support implementation of
EBIs in those clinics and collect high-quality clinic-level data when a
clinic is recruited to participate (baseline) and annually thereafter
to monitor EBI implementation and assess screening rate changes. DP25-
0012 also requires recipients to conduct a formal capacity/readiness
assessment of potential clinics to implement EBIs, use assessment
findings to select appropriate EBIs for implementation, and provide
clinics with limited financial resources to support follow-up
colonoscopies for under- and uninsured patients after an abnormal CRC
screening test.
CDC proposes three information collections--the Annual Awardee
Survey, the Clinic-Level Data Collection Instrument, and the Quarterly
Program Update--to reflect the strategies and objectives detailed in
DP25-0012. The Annual Awardee Survey assesses program management,
clinic readiness assessment activities, data management, technical
assistance (TA) needs, and partnerships, at the recipient level. CDC
will conduct the survey among all 38 recipients following the end of
each program year. The Clinic-level Information Collection Instrument
assesses health system and clinic characteristics; program reach; CRC
screening practices and outcomes; clinics' quality improvement and
monitoring activities; EBI implementation, and additional factors that
affect EBI implementation over time. Clinic-level information will be
collected from all 38 recipients within three months after the end of
each program year. The Quarterly Program Update will collect
standardized recipient-level information on aspects of program
management, including: (1) quarterly program expenditures; (2) current
staff vacancies; (3) program successes and challenges; and (4) current
TA needs at the recipient level. These data are collected quarterly to
enable rapid reporting of programmatic information to support CDC
program consultants in providing tailored and meaningful TA. The
Quarterly Program Update will be administered among all 38 recipients
in the month following each program quarter (i.e., December, March,
June, September).
This information collection enables CDC to gauge progress in
meeting
[[Page 61231]]
CRCCP program goals and monitor implementation activities, evaluate
outcomes, and identify recipients' TA needs. In addition, data
collected will inform program improvement and help identify successful
activities that need to be maintained, replicated, or expanded.
OMB approval is requested for three years. The total estimated
annualized burden is 699 hours. There is no cost to respondents other
than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Recipients.............. CRCCP Annual 38 1 15/60 10
Awardee Survey.
CRCCP Clinic- 38 20 50/60 633
level
Information
Collection
Instrument.
CRCCP Quarterly 38 4 22/60 56
Program Update.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 699
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-19766 Filed 9-25-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.